Program Schedule - Day Two

Wednesday, October 26, 2016

7:30 - 8:30 am: Breakfast/Registration
Location:
 Annenberg West Lobby

8:30 - 9:00 am: Keynote Address – Therapeutics Frontiers in Oncology (Rudin-Kase Dean’s Lecture*)
Introduction: Miriam Merad, Director, Mount Sinai Immunology Institute, Icahn School of Medicine at Mount Sinai
Speaker: Drew M. Pardoll, Abeloff Professorship of Oncology; Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy; Co-Director, Cancer Immunology, Johns Hopkins School of Medicine

9:05 - 10:00 am: Panel Discussion – Novel Approaches to Drug Screening
Moderator:
 Robert J. DeVita, Director of Medicinal Chemistry, Experimental Therapeutics Institute, Icahn School of Medicine at Mount Sinai
Panelists:

  • Michelle Arkin, Associate Professor, Pharmaceutical Chemistry; Director of Biology, Small Molecule Discovery Center, University of California San Francisco
  • Michael A. Foley, Sanders Director, Tri-Institutional Therapeutics Discovery Institute
  • Geraldine A. Hamilton, President and Chief Scientific Officer, Emulate Inc.
  • Peter Hodder, Executive Director, Discovery Technologies, Amgen
  • David Israel, Director, Cell and Molecular Technologies, GlaxoSmithKline

10:05 - 11:00 am: Panel Discussion – Clinical Trials - Evolving Models and Ethical Issues
Moderator:
 Janice L. Gabrilove, Director, Clinical Research Education Programs, Icahn School of Medicine at Mount Sinai
Panelists:

  • Daniel Burkhoff, Director, Heart Failure Hemodynamics and MCS Research, Cardiovascular Research Foundation
  • Gwen L. Nichols, Site Head, Translational Medicine Oncology, Roche Pharmaceutical Research and Early Development
  • Nicholas J. Schork, Professor and Director of Human Biology, J. Craig Venter Institute
  • Gilles Tamagnan, Institute for Neurodegenerative Disorders

11:00 - 11:30 am: Break
Location: 
Annenberg West Lobby

11:30 am - 12:00 pm: Keynote Address – Health Disparities and the Developing World
Introduction: Prabhjot Singh, Director, Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai
Speaker: Suprotik Basu, Chief Executive Officer, UN Secretary-General's Special Envoy for Health in Agenda 2030 and for Malaria

12:05 - 1:00 pm: Panel Discussion – Funding Therapeutic Discovery in Academia
Moderator: Erik Lium, Senior Vice President, Mount Sinai Innovation Partners, Icahn School of Medicine at Mount Sinai
Panelists:

  • Lisa Boyette, CEO, Curable
  • Barbara Mroczkowski, Special Assistant to the Deputy for Clinical and Translational Research, National Cancer Institute
  • Jeffrey S. Nye, Vice President, Neuroscience Innovation and Scientific Partnership Strategy, Johnson & Johnson Innovation; Adjunct Associate Professor, Northwestern University
  • Carlo Rizzuto, Partner, Versant Ventures
  • Amir Tamiz, Program Director, National Institute of Neurological Disorders and Stroke, Office of Translational Research

1:00 - 1:30 pm: Presentations for SINAIMedmaker Challenge and Young Innovators Pitch Competition

1:30 - 1:45 pm: Closing Remarks
Scott L. Friedman, Dean for Therapeutic Discovery, Icahn School of Medicine at Mount Sinai

*The Rudin-Kase Dean's Lecture Series was established in 2002 at Icahn School of Medicine at Mount Sinai with a generous grant from the May and Samuel Rudin Family Foundation, Inc.